You are currently viewing Ciloa part of the French Delegation at BIO US 2025

Ciloa is proud to be part of the French Delegation at BIOUS 2025 Let’s connect and share about our sEV bioengineering platform EVENGI and in progress applications of our lead candidate, APN-sEV. 

Learn more about our breakthrough solution for obesity, diabetes, MASH and metabolic diseases based on adiponectin, a hormone known as the “Guardian Angel” for its anti-inflammatory, anti-oxidative stress, and insulin-sensitizing properties.

BIO US 2025

Business France Healthcare